| Pembrolizumab for persistent, recurrent, or metastatic cervical cancer N Colombo, C Dubot, D Lorusso, MV Caceres, K Hasegawa, ... New England Journal of Medicine 385 (20), 1856-1867, 2021 | 546 | 2021 |
| Clinical activity and safety of the anti–programmed death 1 monoclonal antibody dostarlimab for patients with recurrent or advanced mismatch repair–deficient endometrial cancer … A Oaknin, AV Tinker, L Gilbert, V Samouëlian, C Mathews, J Brown, ... JAMA oncology 6 (11), 1766-1772, 2020 | 290 | 2020 |
| Survival with cemiplimab in recurrent cervical cancer KS Tewari, BJ Monk, I Vergote, A Miller, AC de Melo, HS Kim, YM Kim, ... New England Journal of Medicine 386 (6), 544-555, 2022 | 225 | 2022 |
| Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient … A Oaknin, L Gilbert, AV Tinker, J Brown, C Mathews, J Press, R Sabatier, ... Journal for immunotherapy of cancer 10 (1), 2022 | 194 | 2022 |
| Green versus blue: randomized controlled trial comparing indocyanine green with methylene blue for sentinel lymph node detection in endometrial cancer A Rozenholc, V Samouelian, T Warkus, P Gauthier, D Provencher, ... Gynecologic oncology 153 (3), 500-504, 2019 | 82 | 2019 |
| Enhanced recovery after surgery: implementing a new standard of surgical care AD Altman, L Helpman, J McGee, V Samouëlian, MH Auclair, H Brar, ... Cmaj 191 (17), E469-E475, 2019 | 77 | 2019 |
| Chemosensitivity and radiosensitivity profiles of four new human epithelial ovarian cancer cell lines exhibiting genetic alterations in BRCA2, TGFβ-RII, KRAS2, TP53 and/or … V Samouelian, CM Maugard, M Jolicoeur, R Bertrand, SL Arcand, ... Cancer chemotherapy and pharmacology 54, 497-504, 2004 | 76 | 2004 |
| Prospective cohort study comparing quality of life and sexual health outcomes between women undergoing robotic, laparoscopic and open surgery for endometrial cancer SE Ferguson, T Panzarella, S Lau, LT Gien, V Samouëlian, C Giede, ... Gynecologic oncology 149 (3), 476-483, 2018 | 67 | 2018 |
| Canadian high risk endometrial cancer (CHREC) consortium: analyzing the clinical behavior of high risk endometrial cancers AD Altman, SE Ferguson, EG Atenafu, M Köbel, JN McAlpine, ... Gynecologic oncology 139 (2), 268-274, 2015 | 58 | 2015 |
| VP4-2021: EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9: Interim analysis of phase III trial of cemiplimab vs. investigator's choice (IC) chemotherapy (chemo) in recurrent/metastatic … KS Tewari, BJ Monk, I Vergote, A Miller, AC De Melo, HS Kim, YM Kim, ... Annals of oncology 32 (7), 940-941, 2021 | 44 | 2021 |
| Virtual reality robotic surgery simulation curriculum to teach robotic suturing: a randomized controlled trial DJ Kiely, WH Gotlieb, S Lau, X Zeng, V Samouelian, AV Ramanakumar, ... Journal of robotic surgery 9, 179-186, 2015 | 44 | 2015 |
| Vacuum-assisted closure therapy in the management of patients undergoing vulvectomy F Narducci, V Samouelian, V Marchaudon, P Koenig, C Fournier, ... European Journal of Obstetrics & Gynecology and Reproductive Biology 161 (2 …, 2012 | 44 | 2012 |
| Treatment related outcomes in high-risk endometrial carcinoma: Canadian high risk endometrial cancer consortium (CHREC) MQ Bernardini, LT Gien, S Lau, AD Altman, B Gilks, SE Ferguson, ... Gynecologic Oncology 141 (1), 148-154, 2016 | 41 | 2016 |
| The choice of approach in the surgical management of endometrial carcinoma: a retrospective serie of 155 cases B Occelli, V Samouelian, F Narducci, E Leblanc, D Querleu Bulletin du Cancer 90 (4), 347-355, 2003 | 39 | 2003 |
| An international randomized phase III trial comparing radical hysterectomy and pelvic node dissection (RH) vs simple hysterectomy and pelvic node dissection (SH) in patients … M Plante, JS Kwon, S Ferguson, V Samouëlian, G Ferron, A Maulard, ... Journal of Clinical Oncology 41 (17_suppl), LBA5511-LBA5511, 2023 | 29 | 2023 |
| Error reporting from the da Vinci surgical system in robotic surgery: A Canadian multispecialty experience at a single academic centre E Rajih, C Tholomier, B Cormier, V Samouëlian, T Warkus, M Liberman, ... Canadian Urological Association Journal 11 (5), E197, 2017 | 29 | 2017 |
| Microcystic, elongated, and fragmented pattern invasion is mainly associated with isolated tumor cell pattern metastases in International Federation of Gynecology and … MP Pelletier, VQ Trinh, P Stephenson, AM Mes-Masson, V Samouelian, ... Human Pathology 62, 33-39, 2017 | 28 | 2017 |
| Variation in practice in endometrial cancer and potential for improved care and equity through molecular classification A Jamieson, J Huvila, EF Thompson, S Leung, D Chiu, A Lum, ... Gynecologic oncology 165 (2), 201-214, 2022 | 25 | 2022 |
| Adjuvant treatment for endometrial cancer: literature review and recommendations by the Comité de l'évolution des pratiques en oncologie (CEPO) M Morneau, W Foster, M Lalancette, T Van Nguyen-Huynh, MC Renaud, ... Gynecologic Oncology 131 (1), 231-240, 2013 | 24 | 2013 |
| Grade and estrogen receptor expression identify a subset of no specific molecular profile endometrial carcinomas at a very low risk of disease-specific death A Jamieson, J Huvila, D Chiu, EF Thompson, S Scott, S Salvador, D Vicus, ... Modern Pathology 36 (4), 100085, 2023 | 23 | 2023 |
